Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 239Terminated 77Active not recruiting 38Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 2Thoracic 1

Conditions

Plasmablastic Lymphoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lung Neoplasms 1Hodgkin Disease 1Burkitt Lymphoma 1

Interventions

Carboplatin 8Paclitaxel 7Taxes 6Cisplatin 6pembrolizumab 5Surgical Procedures, Operative 4Platinum 4Capecitabine 41,2-diaminocyclohexaneplatinum II citrate 4Radiotherapy, Intensity-Modulated 3Metformin 3Fluorouracil 3Etoposide 3Doxorubicin 3Cyclophosphamide 3Brachytherapy 3folfirinox 2aumolertinib 2Radiotherapy, Conformal 2Radiotherapy 2Proton Therapy 2Prednisone 2Oxaliplatin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Ifosfamide 2Gemcitabine 2Folfox protocol 2Drug Therapy 2Docetaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Has results × Etoposide × Clear all
NCT00632853 2023-06-12

Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

Alliance for Clinical Trials in Oncology

Phase 3 Unknown
731 enrolled 11 charts
Thoracic

Lung Neoplasms

NCT03077828 2023-06-02

Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Northwestern University

Phase 2 Unknown
43 enrolled 9 charts
Lymphoid

Hodgkin Disease

NCT02481310 2022-02-21

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

Northwestern University

Phase 1/2 Unknown
38 enrolled 12 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡